These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20206921)

  • 21. Bystander help within a polyepitope DNA vaccine improves immune responses to influenza antigens.
    Baird M; Wilson R; Young L; Williman J; Young S; Wilson M; Slobbe L; Lockhart E; Buchan G
    Scand J Immunol; 2004 Oct; 60(4):363-71. PubMed ID: 15379861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of type III pneumococcal polysaccharide-specific suppressor T cells in cyclophosphamide-treated mice requirement for recognition of antigen and I-J determinants on antigen coupled to syngeneic spleen cells.
    Braley-Mullen H
    J Immunol; 1983 Nov; 131(5):2190-5. PubMed ID: 6195257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
    Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
    Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.
    Takeda K; Dow SW; Miyahara N; Kodama T; Koya T; Taube C; Joetham A; Park JW; Dakhama A; Kedl RM; Gelfand EW
    J Immunol; 2009 Jul; 183(1):181-90. PubMed ID: 19542429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differences in the properties of specific T-suppressors and cytotoxic T-lymphocytes immune to H-2 complex antigens].
    Abronina IF; Karaulov AV; Brondz BD
    Biull Eksp Biol Med; 1980 Dec; 90(12):703-5. PubMed ID: 6451245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cells.
    Kloke O; Haubeck HD; Kölsch E
    Eur J Immunol; 1986 Jun; 16(6):659-64. PubMed ID: 2424769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells.
    Traverso I; Fenoglio D; Negrini S; Parodi A; Battaglia F; Kalli F; Conteduca G; Tardito S; Traverso P; Indiveri F; Filaci G
    Hum Immunol; 2012 Mar; 73(3):207-13. PubMed ID: 22285846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
    Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
    Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
    Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
    J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.
    Gribben JG; Ryan DP; Boyajian R; Urban RG; Hedley ML; Beach K; Nealon P; Matulonis U; Campos S; Gilligan TD; Richardson PG; Marshall B; Neuberg D; Nadler LM
    Clin Cancer Res; 2005 Jun; 11(12):4430-6. PubMed ID: 15958627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor.
    Eto M; Kamiryo Y; Takeuchi A; Harano M; Tatsugami K; Harada M; Kiyoshima K; Hamaguchi M; Teshima T; Tsuneyoshi M; Yoshikai Y; Naito S
    Clin Cancer Res; 2008 May; 14(9):2833-40. PubMed ID: 18451251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self.
    Vargo PM; Battisto JR
    J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treg suppress CTL responses upon immunization with HSP gp96.
    Liu Z; Li X; Qiu L; Zhang X; Chen L; Cao S; Wang F; Meng S
    Eur J Immunol; 2009 Nov; 39(11):3110-20. PubMed ID: 19839010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response.
    Hu XD; Chen ST; Li JY; Yu DH; Yi-Zhang ; Cai H
    Vaccine; 2010 Mar; 28(12):2408-15. PubMed ID: 20064480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low doses of cyclophosphamide and low doses of irradiation on the regulation of induced erythrocyte autoantibodies in mice.
    Hutchings P; Naor D; Cooke A
    Immunology; 1985 Jan; 54(1):97-104. PubMed ID: 2579022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine.
    Luby TM
    Expert Rev Vaccines; 2008 Sep; 7(7):995-1003. PubMed ID: 18767949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of cytostatic activity of macrophages against MOPC-315 tumour cells by combined cyclophosphamide administration and immunisation with glutaraldehyde-treated tumour cells.
    Ophir R; Ben-Efraim S; Relyveld EH
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):175-80. PubMed ID: 6241828
    [No Abstract]   [Full Text] [Related]  

  • 40. Ifosfamide and cyclophosphamide: effects on immunosurveillance.
    Binotto G; Trentin L; Semenzato G
    Oncology; 2003; 65 Suppl 2():17-20. PubMed ID: 14586142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.